Almirall exercises call option to acquire ThermiGen
Almirall, a pharmaceutical company based in Barcelona, has exercised a call option to acquire 100 per cent of the share capital of ThermiGen, a privately held medical aesthetics technology company and a developer and manufacturer of thermistor-regulated energy systems for plastic surgery and aesthetics dermatology applications. In September 2015, Almirall